UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Knowing when a retirement plan outperforms a 401k can significantly influence your retirement strategy. Find out the critical factors to consider.
27,035 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
In March 2026, XRP and Ethereum trade near multi-month lows. This piece analyzes how far a $1,000 bet could grow in e...
Workday delivered a stronger-than-expected earnings beat, but the market fixated on AI-driven demand shifts that coul...
Lawyers for Luigi Mangione ask a federal judge to delay the federal murder trial and move the state case to September...
A late-stage private AI company is inviting retail buyers to participate in a sub-$1 pre-IPO round, with shares at $0...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
Oil futures rose late Thursday as tensions in the Persian Gulf flared again, while stock-market futures were muted af...
EMB holds near the high end of its range as volatility fades, but a shift in the 10-year yield, policy signals, or EM...
Noland Arbaugh reflects on life 18 months after becoming first brain-chip recipient, detailing financial shifts in he...
Deutsche Bank upgrades Humana to Buy with a near-doubling price target, as analysts anticipate a 2026 rebound in Medi...
Nasdaq secures conditional SEC clearance to list Bitcoin index options, signaling a broader, more regulated derivativ...
A Deloitte-recognized fast-growing software company launches a phone-scrolling earnings program, sending shares aroun...